Portal de Periódicos da CAPES

Immunization of Patients with Malignant Melanoma with Autologous CD34 + Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I Trial

2003; Mary Ann Liebert, Inc.; Volume: 14; Issue: 14 Linguagem: Inglês

10.1089/104303403322319426

1557-7422

Massimo Di Nicola, Carmelo Carlo‐Stella, Andrea Anichini, Roberta Mortarini, Anna Guidetti, Gabrina Tragni, Gianfrancesco Gallino, Michele Del Vecchio, Fernando Ravagnani, Daniele Morelli, Paul Chaplin, Nathaly Arndtz, Gerd Sutter, Ingo Drexler, Giorgio Parmiani, Natale Cascinelli, Alessandro M. Gianni,

CAR-T cell therapy research

Human Gene TherapyVol. 14, No. 14 Clinical ProtocolImmunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I TrialMassimo Di Nicola, Carmelo Carlo-Stella, Andrea Anichini, Roberta Mortarini, Anna Guidetti, Gabrina Tragni, Francesco Gallino, Michele Del Vecchio, Fernando Ravagnani, Daniele Morelli, Paul Chaplin, Nathaly Arndtz, Gerd Sutter, Ingo Drexler, Giorgio Parmiani, Natale Cascinelli, and Alessandro M. GianniMassimo Di NicolaSearch for more papers by this author, Carmelo Carlo-StellaSearch for more papers by this author, Andrea AnichiniSearch for more papers by this author, Roberta MortariniSearch for more papers by this author, Anna GuidettiSearch for more papers by this author, Gabrina TragniSearch for more papers by this author, Francesco GallinoSearch for more papers by this author, Michele Del VecchioSearch for more papers by this author, Fernando RavagnaniSearch for more papers by this author, Daniele MorelliSearch for more papers by this author, Paul ChaplinSearch for more papers by this author, Nathaly ArndtzSearch for more papers by this author, Gerd SutterSearch for more papers by this author, Ingo DrexlerSearch for more papers by this author, Giorgio ParmianiSearch for more papers by this author, Natale CascinelliSearch for more papers by this author, and Alessandro M. GianniSearch for more papers by this authorPublished Online:7 Jul 2004https://doi.org/10.1089/104303403322319426AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byType I interferon signaling limits viral vector priming of CD8 + T cells during initiation of vitiligo and melanoma immunotherapy26 October 2020 | Pigment Cell & Melanoma Research, Vol. 34, No. 4Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma27 February 2014 | Gene Therapy, Vol. 21, No. 5Co-transfection of dendritic cells with AFP and IL-2 genes enhances the induction of tumor antigen-specific antitumor immunity6 July 2012 | Experimental and Therapeutic Medicine, Vol. 4, No. 4Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment11 January 2012 | International Journal of Hyperthermia, Vol. 28, No. 1Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells29 November 2011 | Scientific Reports, Vol. 1, No. 1Improvement of dendritic-based vaccine efficacy against hepatitis B virus–related hepatocellular carcinoma by two tumor-associated antigen gene–infected dendritic cellsHuman Immunology, Vol. 71, No. 3Effects of Herpes Simplex Virus Amplicon Transduction on Murine Dendritic Cells Yahui Grace Chiu, William J. Bowers, Seung T. Lim, Deborah A. Ryan, and Howard J. Federoff1 April 2009 | Human Gene Therapy, Vol. 20, No. 5Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse modelVaccine, Vol. 25, No. 20Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicityVirology, Vol. 350, No. 2Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors15 December 2005 | Gene Therapy, Vol. 13, No. 7Nucleic Acid Transfer26 March 2008From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy1 January 2005 | The Journal of Gene Medicine, Vol. 8, No. 1Fighting Cancer with Vaccinia Virus: Teaching New Tricks to an Old DogMolecular Therapy, Vol. 11, No. 2Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?Current Opinion in Biotechnology, Vol. 15, No. 6Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells1 January 2004 | The Journal of Gene Medicine, Vol. 6, No. 11Side-by-Side Comparison of Lentivirally Transduced and mRNA-Electroporated Dendritic Cells: Implications for Cancer Immunotherapy ProtocolsMolecular Therapy, Vol. 10, No. 4Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell Vaccination24 August 2004 | Clinical Cancer Research, Vol. 10, No. 16 Volume 14Issue 14Sep 2003 To cite this article:Massimo Di Nicola, Carmelo Carlo-Stella, Andrea Anichini, Roberta Mortarini, Anna Guidetti, Gabrina Tragni, Francesco Gallino, Michele Del Vecchio, Fernando Ravagnani, Daniele Morelli, Paul Chaplin, Nathaly Arndtz, Gerd Sutter, Ingo Drexler, Giorgio Parmiani, Natale Cascinelli, and Alessandro M. Gianni.Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I Trial.Human Gene Therapy.Sep 2003.1347-1360.http://doi.org/10.1089/104303403322319426Published in Volume: 14 Issue 14: July 7, 2004PDF download